UniProtKB/Swiss-Prot Q01546: Variant p.Ala359Thr

Keratin, type II cytoskeletal 2 oral
Gene: KRT76
Feedback?

Variant information Variant position:

359 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Alanine (A) to Threonine (T) at position 359 (A359T, p.Ala359Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from small size and hydrophobic (A) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs6580904 [ dbSNP | Ensembl ]

Sequence information Variant position:

359 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

638 The length of the canonical sequence.
Location on the sequence:

VLSMDNNRCLDLGSIIAEVR A QYEEIAQRSKSEAEALYQTK The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         VLSMDNNRCLDLGSIIAEVRAQYEEIAQRSKSEAEALYQTK

Mouse                         VLSMDNNRCLDLDSIIAEVKAQYEDIAQKSKAEAEALYQTK

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 638	Keratin, type II cytoskeletal 2 oral
Domain	183 – 496	IF rod
Region	354 – 492	Coil 2

Literature citations
Suprabasal marker proteins distinguishing keratinizing squamous epithelia: cytokeratin 2 polypeptides of oral masticatory epithelium and epidermis are different.
Collin C.; Ouhayoun J.P.; Grund C.; Franke W.W.;
Differentiation 51:137-148(1992)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; FUNCTION; DEVELOPMENTAL STAGE; VARIANT THR-359; Initial characterization of the human central proteome.
Burkard T.R.; Planyavsky M.; Kaupe I.; Breitwieser F.P.; Buerckstuemmer T.; Bennett K.L.; Superti-Furga G.; Colinge J.;
BMC Syst. Biol. 5:17-17(2011)
Cited for: VARIANT [LARGE SCALE ANALYSIS] THR-359; IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS];

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.